Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PAK BioSolutions develops and commercializes automated systems and consumables that enable end-to-end continuous manufacturing of biopharmaceuticals. Their flagship product, the Pilot PAK system, allows simultaneous operation of multiple downstream processing steps—such as chromatography, filtration, virus inactivation, and ultrafiltration/diafiltration—in both laboratory and GMP settings. The company’s technologies are designed to increase productivity while reducing costs and facility footprint for manufacturers of monoclonal antibodies and other biologics. They also provide consulting services to support implementation of continuous processes in biomanufacturing facilities
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PAK BioSolutions.